Ameriprise’s Myovant Sciences Ltd. MYOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-55,025
Closed -$1.48M 4066
2022
Q4
$1.48M Buy
+55,025
New +$1.45M ﹤0.01% 2940

Other funds holding MYOV

Ameriprise's MYOV Position: Q1 2023 in Review

Ameriprise sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 55,025 shares — an estimated $1.48M sold.

Ameriprise first reported a position in MYOV in Q4 2022 and held it in 1 quarter. The position peaked at $1.48M in Q4 2022. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

  • Ameriprise reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
  • Ameriprise sold 55,025 Myovant Sciences Ltd. shares in Q1 2023, an estimated $1.48M.
  • Ameriprise first reported a position in Myovant Sciences Ltd. in Q4 2022 and held it in 1 quarter.
  • Ameriprise's Myovant Sciences Ltd. position peaked at $1.48M in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on Ameriprise's 13F filing for Q1 2023, filed 15 May 2023.